[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Apellis Pharmaceuticals, Inc. Common Stock](/topic/$apls)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$apls/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2025-04-13  
**1-Year Low**: X% on 2025-09-09  

**Most Supportive Themes**
- **Wells Fargo Upgrade:** (15%) Wells Fargo raised Apellis Pharmaceuticals (APLS) target price and rating.
  
**Most Critical Themes**
- **Goldman Sachs Downgrade:** (60%)  Goldman Sachs downgraded Apellis Pharmaceuticals (APLS) to Sell.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | XX       | X% |